Jean‐François Geay
- Hematology top 10%
- Hematopoietic Stem Cell Transplantation 2
- Acute Myeloid Leukemia Research 1
-
- Immunotherapy and Immune Responses 2
-
- Virus-based gene therapy research 1
-
- Chemokine receptors and signaling 2
-
- Sarcoma Diagnosis and Treatment 1
- Advanced Breast Cancer Therapies 1
-
- SARS-CoV-2 and COVID-19 Research 1
- Co-authors
- Peggy JarrierFawzia LouacheYanyan ZhangWilliam VainchenkerAdlen FoudiDorothée Selimoglu‐BuetTakashi NagasawaYann Lécluse
- Cited by
- HematologyImmunologyGenetics
- Partner nations
- FranceSwitzerlandJapan
In The Last Decade
Jean‐François Geay
9 papers receiving 271 citations
Peers
Comparison fields: 5 of 51
- Hematology 123
- Immunology 114
- Genetics 46
- Immunology and Allergy 25
- Oncology 112
Countries citing papers authored by Jean‐François Geay
This map shows the geographic impact of Jean‐François Geay's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jean‐François Geay with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jean‐François Geay more than expected).
Fields of papers citing papers by Jean‐François Geay
This network shows the impact of papers produced by Jean‐François Geay. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jean‐François Geay. The network helps show where Jean‐François Geay may publish in the future.
Co-authorship network
The 24 scholars most cited alongside Jean‐François Geay, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2022 | 2 | |
| 2 | 2018 | 10 | |
| 3 | 2013 | 5 | |
| 4 | [Physiopathology, diagnosis and treatment of breast cancer]. | 2013 | 3 |
| 5 | 2005 | 46 | |
| 6 | 2005 | 97 | |
| 7 | 2004 | 21 | |
| 8 | 2004 | 3 | |
| 9 | 2004 | 89 |
About Jean‐François Geay
Jean‐François Geay is a scholar working on Hematology, Immunology and Allergy and Immunology, having authored 9 papers that have together received 276 indexed citations. Recurring topics across this work include Immunotherapy and Immune Responses (2 papers), Hematopoietic Stem Cell Transplantation (2 papers), Chemokine receptors and signaling (2 papers), Sarcoma Diagnosis and Treatment (1 paper), SARS-CoV-2 and COVID-19 Research (1 paper), Virus-based gene therapy research (1 paper), Acute Myeloid Leukemia Research (1 paper) and Advanced Breast Cancer Therapies (1 paper). The work is most often cited by research in Hematology (123 citations), Immunology (114 citations) and Genetics (46 citations). Jean‐François Geay has collaborated with scholars based in France, Switzerland and Japan. Frequent co-authors include Peggy Jarrier, Fawzia Louache, Yanyan Zhang, William Vainchenker, Adlen Foudi, Dorothée Selimoglu‐Buet, Takashi Nagasawa, Yann Lécluse, M. Wittner and Abdelali Jalil. Their work appears in journals such as Blood, Cancer Research and International Journal of Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.